$4.2B deal: GSK and Merck KGaA to develop cancer immunotherapy
February 05, 2019 at 11:01 AM EST
The deal includes a $343 million upfront payment payment and potential future milestone payments of nearly $3.9 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.